Vaccination campaigns against measles have had dramatic results — but eradicating the disease is still a distant prospect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Strebel, P. M. et al. J. Infect. Dis. doi:10.1093/infds/jir111 (in the press).
van den Ent, M. V. X ., Brown, D. W., Hoekstra, E. J., Christie, A. & Cochi, S. L. J. Infect. Dis. doi:10.1093/infds.jir081 (in the press).
Black, R. E. et al. Lancet 375, 1969-1987 (2010).
European Centre for Disease Prevention and Control. Epidemiological Update on Measles in EU/EEA (2011) available at: go.nature.com/yndhco
Centers for Disease Control and Prevention . MMWR Morb. Mortal. Wkly Rep. 60, 374-378 (2011).
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Vaccines: The case of measles. Nature 473, 434–435 (2011). https://doi.org/10.1038/473434a
Published:
Issue Date:
DOI: https://doi.org/10.1038/473434a
